Save Life Seeds
Extend quality of life

Headquartered in Shenzhen, Shenzhen Chunzhu Century Stem Cell Technology Co., Ltd. is a life sciences enterprise dedicated to the R&D and commercialization of autologous stem cells produced via small-molecule induction technology.

The company possesses a proprietary core technology system, independently developed and protected by patents, enabling the efficient large-scale production of autologous stem cells from patient blood. With 25 years of expertise in small-molecule-induced autologous stem cell technology and industrialization, we have built robust R&D and translation capabilities to produce up to 12 types of autologous stem cells. Our solutions support diverse applications across basic research, clinical trials, and health management.

The company is deepening industry-academia-research collaborative innovation by jointly establishing a stem cell innovation consortium with the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. This initiative accelerates the development of new biomedicine technologies and their clinical translation.

Leveraging its core technology of induced autologous hematopoietic stem cells, Chunzhu Century will continue to advance clinical research on these biomedical innovations across multiple areas, including systemic lupus erythematosus, post-myocardial infarction complications, pulmonary fibrosis, post-stroke sequelae, and diabetes.